Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
15 11 2020
Historique:
received: 10 05 2020
revised: 07 07 2020
accepted: 31 08 2020
pubmed: 5 9 2020
medline: 23 11 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

GEP-NENs are rare malignancies with increasing incidence. Their molecular characteristics are still undefined. We explored the underlying biology of GEP-NENs and the differences between gastrointestinal (GI) and pancreatic (PNEN), high-grade (HG), and low-grade (LG) tumors. GEP-NENs were analyzed using next-generation sequencing (NGS; MiSeq on 47 genes, NextSeq on 592 genes), IHC, and In total, 724 GEP-NENs were examined: GI ( Significant molecular differences were observed in GEP-NENs by tumor location and grade, indicating differences in carcinogenic pathways and biology.

Identifiants

pubmed: 32883742
pii: 1078-0432.CCR-20-1804
doi: 10.1158/1078-0432.CCR-20-1804
pmc: PMC8970533
mid: NIHMS1626670
doi:

Substances chimiques

Biomarkers, Tumor 0
Neoplasm Proteins 0
BRAF protein, human EC 2.7.11.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5943-5951

Subventions

Organisme : NCI NIH HHS
ID : P30 CA014089
Pays : United States

Informations de copyright

©2020 American Association for Cancer Research.

Références

Semin Cancer Biol. 2020 Apr;61:132-138
pubmed: 31577961
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
Neuroendocrinology. 2020;110(7-8):616-629
pubmed: 31557757
Neuroendocrinology. 2011;93(4):249-58
pubmed: 21487213
World J Gastrointest Oncol. 2014 Aug 15;6(8):301-10
pubmed: 25132927
Arch Pathol Lab Med. 2014 Aug;138(8):1027-36
pubmed: 25076292
Nat Rev Clin Oncol. 2016 Nov;13(11):691-705
pubmed: 27273044
Nat Genet. 2013 Dec;45(12):1483-6
pubmed: 24185511
Nature. 2017 Mar 2;543(7643):65-71
pubmed: 28199314
Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):333-342
pubmed: 28400627
J Cancer. 2016 May 25;7(9):1044-8
pubmed: 27326246
Cancer. 2003 Sep 15;98(6):1273-82
pubmed: 12973852
Endocr Relat Cancer. 2010 Aug 16;17(3):771-83
pubmed: 20566584
JCO Precis Oncol. 2018;2018:
pubmed: 30687805
Oncotarget. 2018 Nov 9;9(88):35809-35812
pubmed: 30533196
Science. 2011 Mar 4;331(6021):1199-203
pubmed: 21252315
Cancer Treat Rev. 2017 May;56:28-35
pubmed: 28456055
J Cancer. 2016 Feb 05;7(5):484-9
pubmed: 26958083
Mod Pathol. 2017 Apr;30(4):610-619
pubmed: 28059096
Mod Pathol. 2018 Dec;31(12):1770-1786
pubmed: 30140036
Ann Oncol. 2020 Jul;31(7):844-860
pubmed: 32272208
J Immunother Cancer. 2019 Oct 26;7(1):278
pubmed: 31655605
Anticancer Res. 2016 Mar;36(3):921-4
pubmed: 26976979
Clin Cancer Res. 2016 Jan 1;22(1):250-8
pubmed: 26169971
Br J Cancer. 2020 Apr;122(9):1309-1314
pubmed: 32152503
Curr Opin Endocrinol Diabetes Obes. 2014 Feb;21(1):22-7
pubmed: 24310147
World J Gastroenterol. 2014 Dec 14;20(46):17498-506
pubmed: 25516664
Am J Surg Pathol. 2012 Feb;36(2):173-84
pubmed: 22251937
Nat Genet. 2018 Jul;50(7):979-989
pubmed: 29915428
Br J Cancer. 2016 Aug 23;115(5):564-70
pubmed: 27482646
Expert Rev Gastroenterol Hepatol. 2018 May;12(5):471-478
pubmed: 29629846
CA Cancer J Clin. 2019 Jul;69(4):305-343
pubmed: 31116423
Clin Cancer Res. 2020 May 15;26(10):2290-2296
pubmed: 31969335
J Clin Invest. 2013 Jun;123(6):2502-8
pubmed: 23676460

Auteurs

Alberto Puccini (A)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
University of Genoa, Ospedale Policlinico San Martino IRCCS, Genoa, Italy.

Kelsey Poorman (K)

Caris Life Sciences, Phoenix, Arizona.

Mohamed E Salem (ME)

Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.

Davide Soldato (D)

University of Genoa, Ospedale Policlinico San Martino IRCCS, Genoa, Italy.

Andreas Seeber (A)

Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.

Richard M Goldberg (RM)

West Virginia University Cancer Institute, Morgantown, West Virginia.

Anthony F Shields (AF)

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

Joanne Xiu (J)

Caris Life Sciences, Phoenix, Arizona.

Francesca Battaglin (F)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Martin D Berger (MD)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Ryuma Tokunaga (R)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Madiha Naseem (M)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Afsaneh Barzi (A)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Syma Iqbal (S)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Wu Zhang (W)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Shivani Soni (S)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Jimmy J Hwang (JJ)

Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.

Philip A Philip (PA)

West Virginia University Cancer Institute, Morgantown, West Virginia.

Stefania Sciallero (S)

University of Genoa, Ospedale Policlinico San Martino IRCCS, Genoa, Italy.

W Michael Korn (WM)

Caris Life Sciences, Phoenix, Arizona.

John L Marshall (JL)

Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.

Heinz-Josef Lenz (HJ)

Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California. lenz@med.usc.edu.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH